Stocks
BMY-AZN Merger Denial Puts Pharma M&A Outlook in Focus
A Financial Times report of BMY-AZN merger talks was swiftly denied by Reuters sources, reigniting debate on Big Pharma M&A prospects. Seeking...
A Financial Times report of BMY-AZN merger talks was swiftly denied by Reuters sources, reigniting debate on Big Pharma M&A prospects. Seeking...